MENLO PARK, Calif., March 12 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today announced that Gregory D. Casciaro, President and Chief Executive Officer, will present at Cowen and Company's 28th Annual Health Care Conference on Tuesday, March 18, 2008 at 9:30 a.m. Eastern. This event will be held at the Boston Marriot Copley Place in Boston, MA.
XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device. Note: XTENT Custom NX DES Systems have not been approved for sale by any regulatory authority.
Information about XTENT is available at our website at http://www.xtentinc.com.
|SOURCE XTENT, Inc.|
Copyright©2008 PR Newswire.
All rights reserved